Global Custom Market Research Reports Provider Company

phone

A1M Pharma AB (A1M) - Pharmaceuticals & Healthcare - Deals and Alliances Profile

  • Published Date: 11 Apr 2018
  • Number of Pages: 29
  • Category: Pharmaceuticals
  • Country: Sweden
Summary

A1M Pharma AB (A1M Pharma) develops and commercializes drug candidate for the diagnosis and treatment of pre-eclampsia (pandemic poisoning) and acute renal injury. The company offers ROSgard based on A1M (alpha-1-microglobulin), an endogenous protein with properties that captures and eliminates toxic substances from the cells metabolism. Its A1M helps to prevent and ameliorate some of the damage caused by oxidative stress and inflammation. A1M Pharma develops novel diagnostic test for preeclampsia based on the biomarker fetal hemoglobin. The company also develops treatments for kidney damage. It provides constitute therapeutic or diagnostic tools for various conditions and illnesses in animals and humans. A1M Pharma is headquartered in Lund, Sweden.

A1M Pharma AB (A1M) - Pharmaceuticals & Healthcare - Deals and Alliances Profile provides you comprehensive data and trend analysis of the companys Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals - Analysis of the companys financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year - Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type - Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region - Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector - Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals - Information on the companys major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Companys (major public companies) key financial metrics and ratios.
- Business Description - A brief description of the companys operations.
- Key Employees - A list of the key executives of the company.
- Important Locations and Subsidiaries - A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors - A list of the key competitors of the company.
- Key Recent Developments - A brief on recent news about the company.

Reasons To Buy


Get detailed information on the companys financial deals that enable you to understand the companys expansion/divestiture and fund requirements
- The profile enables you to analyze the companys financial deals by region, by year, by business segments and by type, for a five year period.

Understand the companys business segments expansion / divestiture strategy
- The profile presents deals from the companys core business segments perspective to help you understand its corporate strategy.

Access elaborate information on the companys recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Companys key financial metrics and ratios.

Equip yourself with detailed information about the companys operations to identify potential customers and suppliers.
- The profile analyzes the companys business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.
Publisher Name : GlobalData

3
List of Tables 4
List of Figures 4
A1M Pharma AB, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
A1M Pharma AB, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
A1M Pharma AB, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
A1M Pharma AB, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
A1M Pharma AB, Medical Devices Deals, 2012 to YTD 2018 9
A1M Pharma AB, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10
A1M Pharma AB, Pharmaceuticals & Healthcare, Deal Details 11
Partnerships 11
A1M Pharma Partnered with Clinical Trial Consultants 11
A1M Pharma Enters into Agreement with Research Toxicology Centre 12
A1M Pharma Enters into Research Agreement with CSL Behring 13
A1M Pharma Enters into Rresearch Agreement with Fred Hutchinson Cancer Research Centre 14
A1M Pharma Expands Agreement with European Pharmaceutical Company 15
A1M Pharma Enters into Partnership with Truly Translational 16
NeuroVive Pharmal And A1M Pharma Enter Into Research Agreement 17
Equity Offering 18
A1M Pharma Plans to Raise USD10.5 Million in Rights Offering of Shares 18
A1M Pharma Plans to Raise USD13.82 Million in Public Offering of Shares 19
A1M Pharma Raises USD5 Million in Rights Offering of Shares 20
A1M Pharma Raises USD3.7 Million in Rights Offering of Shares 21
A1M Pharma Raises USD3.61 Million in Rights Offering of Shares 22
A1M Pharma AB - Key Competitors 23
A1M Pharma AB - Key Employees 24
A1M Pharma AB - Locations And Subsidiaries 25
Head Office 25
Other Locations & Subsidiaries 25
Recent Developments 26
Product News 26
02/10/2017: A1M Pharma has successfully conducted large scale manufacturing of the active substance in ROSGard and initiates GLP toxicology studies 26
Clinical Trials 27
Jun 12, 2017: A1M Pharma announces progress in the preclinical development of ROSGard 27
Mar 29, 2017: A1M Pharma: ROSGard shows strong protective effect against renal damage in connection with radiation therapy in a preclinical long-term study 28
Appendix 29
Methodology 29
About GlobalData 29
Contact Us 29
Disclaimer 29

List Of Tables

List of Tables
A1M Pharma AB, Pharmaceuticals & Healthcare, Key Facts 2
A1M Pharma AB, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
A1M Pharma AB, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
A1M Pharma AB, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
A1M Pharma AB, Deals By Therapy Area, 2012 to YTD 2018 8
A1M Pharma AB, Medical Devices Deals, 2012 to YTD 2018 9
A1M Pharma AB, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10
A1M Pharma Partnered with Clinical Trial Consultants 11
A1M Pharma Enters into Agreement with Research Toxicology Centre 12
A1M Pharma Enters into Research Agreement with CSL Behring 13
A1M Pharma Enters into Rresearch Agreement with Fred Hutchinson Cancer Research Centre 14
A1M Pharma Expands Agreement with European Pharmaceutical Company 15
A1M Pharma Enters into Partnership with Truly Translational 16
NeuroVive Pharmal And A1M Pharma Enter Into Research Agreement 17
A1M Pharma Plans to Raise USD10.5 Million in Rights Offering of Shares 18
A1M Pharma Plans to Raise USD13.82 Million in Public Offering of Shares 19
A1M Pharma Raises USD5 Million in Rights Offering of Shares 20
A1M Pharma Raises USD3.7 Million in Rights Offering of Shares 21
A1M Pharma Raises USD3.61 Million in Rights Offering of Shares 22
A1M Pharma AB, Key Competitors 23
A1M Pharma AB, Key Employees 24
A1M Pharma AB, Subsidiaries 25

List Of Figures

List of Figures
A1M Pharma AB, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
A1M Pharma AB, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
A1M Pharma AB, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2
A1M Pharma AB, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2
A1M Pharma AB, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
A1M Pharma AB, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 6
A1M Pharma AB, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
A1M Pharma AB, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
A1M Pharma AB, Medical Devices Deals, 2012 to YTD 2018 9

A1M Pharma AB (A1M Pharma) develops and commercializes drug candidate for the diagnosis and treatment of pre-eclampsia (pandemic poisoning) and acute renal injury. The company offers ROSgard based on A1M

View Report

A1M Pharma AB (A1M Pharma) is a developer of a drug candidate for the diagnosis and treatment of pre-eclampsia and acute renal injury. The company offers A1M, an endogenous protein

View Report
There is no reviews available for this report

Select License Type

Delivery Details

Delivery Details : Electronic files (PDF) of market research reports will dispatched within 12 to 24 hours. (Mon-Fri IST)

Customized Report

If a particular report is not as per your requirement you can ‎choose "Customized Report". To visit click on -

Custom Research Reports